Treatment of Rivaroxaban Versus Aspirin for Non-disabling Cerebrovascular Events
Clinical trial NCT01923818 · UNKNOWN
Trial details
- NCT number
- NCT01923818
- Sponsor
- Xijing Hospital
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2015-09-01
- Enrollment
- 3700
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.